Respiri Limited Appoints Brad Snow as A Non-Executive Director
AngelMed's novel device, The Guardian System, is the world's first and only FDA approved real-time implantable cardiac device to detect acute coronary syndrome events, including silent heart attacks. Previous, Brad was Chief Executive Officer and Board of Director of SonaCare Medical, LLC (now Sonablate Corp), a global company with a cutting edge (HIFU) ultrasound imaging, assessment and ablation system. Under his leadership, SonaCare carried out a successful capital raise and also secured a substantial sales distribution agreement. Mr. Snow provided Med-Tech Consulting which provided advisory services to medical technology clients in relation to commercial strategy, operational improvements, business development and funding. During the same
period, he also co-founded DisruptRxtech.com, an artificial intelligence healthcare IT company. Earlier in his career, Mr. Snow held executive leadership roles in sales, marketing and commercial operations for numerous start-up and emerging growth companies: BTGplc, ARAGON Surgical, Rubicor, Fox Hollow Technologies etc. in the med-tech space.